Royal Biologics Announces FDA Approval of the Maxx™ Concentration System.
08 sept. 2021 09h12 HE
|
Royal Biologics
HACKENSACK, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Royal Biologics, an ortho-biologics company focused on Autologous and Live Cellular solutions, has announced FDA 510K approval of their Maxx™-PRP...